Stiefel Laboratories (U.K.) Ltd
- Company number
- 00831160
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 15 Dec 1964
- Nature of business
- Non-trading company
- Corporate group
- 1 Clinical Ltd (50742 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GUITTARD, Laura | Director | 11 Jan 2022 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Gsk Finance (No 2) Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
19 Aug 2021 | |
| Setfirst Limited | Ownership Of Shares 50 To 75 Percent Voting Rights 50 To 75 Percent Right To Appoint And Remove Directors |
6 Apr 2016 | |
| Glaxosmithkline Finance Plc | Ownership Of Shares 25 To 50 Percent Ownership Of Shares 25 To 50 Percent As Firm Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
6 Apr 2016 | 19 Aug 2021 |
Accounts
Connections
Owned by
Stiefel Laboratories (U.K.) Ltd → GSK Finance (No 2) Limited → Glaxosmithkline Finance PLC → Glaxosmithkline Holdings Limited → GSK PLC
Directors’ other companies
- GUITTARD, Laura - Director at Glaxosmithkline Holdings (One) Limited
- GUITTARD, Laura - Director at Smithkline Beecham (Investments) Limited
- GUITTARD, Laura - Director at Tesaro UK Limited
Companies at the same address
- Aiolos Bio Limited (14956089)
- Allen & Hanburys Limited (00040209)
- Beecham Group PLC (00227531)
- Berkeley Square Common Investment Fund (No. 2) Limited (06273783)
- Berkeley Square Common Investment Fund Limited (05269762)
- British Pharma Group Limited (02538510)
- Burroughs Wellcome International Limited (00543757)
- Clarges Pharmaceuticals Trustees Limited (01418508)
- Dealcyber Limited (03541898)
- Eskaylab Limited (00099025)